BeiGene pays $270m for PD-1 antibody boosting drug 10-Apr-2019 By Ben Hargreaves BeiGene partners with BioAtla to develop and commercialise the latter’s CTLA-4 antibody, which will be explored for use alongside a PD-1 antibody.